The final score was calculated using (i) the scaled sum of B cells and FDC CD21+ CD23- densities (log10), and (ii) the TLS scaled relative area, which were the three most prognostically relevant and robust TLS features in this NSCLC cohort. Here, CR2 is linked to non-small cell lung carcinoma.